Immunic | VTL - Equity Capital And Reserves


Immunic reported $151.23M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Alterity Therapeutics Limited AUD 36.21M 18.58M Dec/2025
BioMarin Pharmaceutical USD 6.21B 125.11M Mar/2026
Cipla INR 344.32B 15.13B Mar/2026
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 102.73M 58.9M Dec/2025
CSL USD 18.66B 2.75B Dec/2025
Enanta Pharmaceuticals USD 126.59M 61.87M Dec/2025
Grifols EUR 6.21B 133.12M Dec/2025
Immunic USD 151.23M 157.91M Mar/2026
Insmed USD 704.85M 34.12M Mar/2026
Omeros USD -228.68M 15.13M Jun/2025
OraSure Technologies USD 313.32M 27.5M Mar/2026
Quidel USD 1.85B 69.1M Mar/2026
Ultragenyx Pharmaceutical USD -236M 156M Mar/2026
United Therapeutics USD 5.9B 1.2B Mar/2026
Xoma USD 87.94M 15.5M Sep/2025